Amalgamated Bank Has $725,000 Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

Amalgamated Bank reduced its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 36.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,508 shares of the company's stock after selling 8,338 shares during the period. Amalgamated Bank's holdings in Azenta were worth $725,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in AZTA. Farther Finance Advisors LLC boosted its stake in shares of Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock valued at $74,000 after buying an additional 256 shares during the period. KBC Group NV boosted its position in Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after purchasing an additional 698 shares during the last quarter. Assenagon Asset Management S.A. acquired a new stake in Azenta during the fourth quarter valued at $200,000. Aigen Investment Management LP purchased a new position in Azenta in the third quarter valued at about $214,000. Finally, Empowered Funds LLC acquired a new position in Azenta in the 4th quarter worth about $293,000. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Stock Performance

Azenta stock traded up $0.65 on Thursday, reaching $41.59. The company's stock had a trading volume of 273,996 shares, compared to its average volume of 574,051. The business's fifty day moving average price is $49.80 and its 200 day moving average price is $47.55. The company has a market cap of $1.90 billion, a price-to-earnings ratio of -13.98 and a beta of 1.47. Azenta, Inc. has a twelve month low of $38.82 and a twelve month high of $67.77.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. As a group, equities analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

AZTA has been the subject of several analyst reports. Stephens reaffirmed an "overweight" rating and issued a $60.00 price objective on shares of Azenta in a research note on Thursday, January 2nd. TD Cowen raised Azenta to a "hold" rating in a research report on Thursday, February 27th. Evercore ISI increased their price objective on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Finally, Needham & Company LLC boosted their target price on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $58.75.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.